Vineet Laboratories
41.18
+1.72(+4.36%)
Market Cap₹36.40 Cr
PE Ratio-1.97
IndustryHealthcare
Company Performance:
1D+4.36%
1M+16.66%
6M+25.78%
1Y-29.83%
5Y-10.87%
View Company Insightsright
Latest news about Vineet Laboratories
Vineet Laboratories Promoters Reduce Stakes in Separate Transactions Aug 18, 2025
Vineet Laboratories Seeks Shareholder Approval for Capital Increase and Director Appointment Aug 12, 2025
Vineet Laboratories Promoters Reduce Stakes, Sell Shares Worth Over ₹3 Crore Aug 09, 2025
Vineet Laboratories Promoters Offload Shares Worth Over ₹1.4 Crore Aug 08, 2025
More news about Vineet Laboratories
24Jul 25
Vineet Laboratories Promoter Reduces Stake Through Two Share Sale Transactions
Valluru Vara Prasad Rao, a promoter of Vineet Laboratories Limited, has reduced his shareholding through two separate transactions on the NSE. The first sale of 607 shares reduced his stake from 17.97% to 17.37%. The second sale of 14,000 shares further decreased his holding to 14.15%. In total, the promoter's stake has been reduced by approximately 3.82 percentage points. The company has duly informed the stock exchanges about these transactions in compliance with SEBI regulations.
22Jul 25
Vineet Laboratories Reports Reduced Net Loss in Q1 FY2026
Vineet Laboratories Limited (VLL) reported a net loss of ₹86.61 lakh for Q1 FY2026, improving from a ₹213.07 lakh loss in Q1 FY2025. However, revenue declined sharply to ₹744.18 lakh from ₹2,386.16 lakh year-over-year. Total expenses were ₹836.14 lakh. The company's EPS improved to -₹0.94 from -₹2.31. As of June 30, 2025, total assets stood at ₹8,854.38 lakh, with total equity at ₹1,382.00 lakh. The Board approved these results on July 22, 2025, and auditors NSVR & Associates LLP issued an unqualified review report.
Vineet Laboratories
41.18
+1.72
(+4.36%)
1 Year Returns:-29.83%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)